SUNLIGHT Trademark

Trademark Overview

On Friday, December 17, 2021, a trademark application was filed for SUNLIGHT with the United States Patent and Trademark Office. The USPTO has given the SUNLIGHT trademark a serial number of 97177416. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, June 1, 2024. This trademark is owned by BIOFARMA. The SUNLIGHT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
sunlight

General Information

Serial Number97177416
Word MarkSUNLIGHT
Filing DateFriday, December 17, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, June 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSURESNES cedex 92284
FR

Trademark Events

Event DateEvent Description
Tuesday, December 21, 2021NEW APPLICATION ENTERED
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 23, 2022ASSIGNED TO EXAMINER
Tuesday, September 27, 2022SUSPENSION LETTER WRITTEN
Tuesday, September 27, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, September 27, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 13, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 28, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 14, 2023ASSIGNED TO LIE
Thursday, September 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2023NON-FINAL ACTION WRITTEN
Thursday, October 12, 2023NON-FINAL ACTION E-MAILED
Thursday, October 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 1, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, June 1, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, February 9, 2024NON-FINAL ACTION WRITTEN
Friday, February 9, 2024NON-FINAL ACTION E-MAILED
Friday, February 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

sunlight pharmaceuticals clinical trials field information medical scientific research providing